falseQ1000008894101/252026P1YP2YP1YP2Y0.02683250.049081http://fasb.org/us-gaap/2024#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2024#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrentxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pureutr:Dsmtc:numberOfLeasessmtc:segment00000889412025-01-272025-04-2700000889412025-05-230000088941us-gaap:ProductMember2025-01-272025-04-270000088941us-gaap:ProductMember2024-01-292024-04-280000088941us-gaap:ServiceMember2025-01-272025-04-270000088941us-gaap:ServiceMember2024-01-292024-04-2800000889412024-01-292024-04-280000088941us-gaap:ForeignExchangeContractMember2025-01-272025-04-270000088941us-gaap:ForeignExchangeContractMember2024-01-292024-04-280000088941us-gaap:InterestRateSwapMember2025-01-272025-04-270000088941us-gaap:InterestRateSwapMember2024-01-292024-04-2800000889412025-04-2700000889412025-01-260000088941us-gaap:CommonStockMember2025-01-260000088941us-gaap:TreasuryStockCommonMember2025-01-260000088941us-gaap:AdditionalPaidInCapitalMember2025-01-260000088941us-gaap:RetainedEarningsMember2025-01-260000088941us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-260000088941us-gaap:ParentMember2025-01-260000088941us-gaap:NoncontrollingInterestMember2025-01-260000088941us-gaap:RetainedEarningsMember2025-01-272025-04-270000088941us-gaap:ParentMember2025-01-272025-04-270000088941us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-272025-04-270000088941us-gaap:AdditionalPaidInCapitalMember2025-01-272025-04-270000088941us-gaap:CommonStockMember2025-01-272025-04-270000088941us-gaap:TreasuryStockCommonMember2025-01-272025-04-270000088941us-gaap:CommonStockMember2025-04-270000088941us-gaap:TreasuryStockCommonMember2025-04-270000088941us-gaap:AdditionalPaidInCapitalMember2025-04-270000088941us-gaap:RetainedEarningsMember2025-04-270000088941us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-04-270000088941us-gaap:ParentMember2025-04-270000088941us-gaap:NoncontrollingInterestMember2025-04-270000088941us-gaap:CommonStockMember2024-01-280000088941us-gaap:TreasuryStockCommonMember2024-01-280000088941us-gaap:AdditionalPaidInCapitalMember2024-01-280000088941us-gaap:RetainedEarningsMember2024-01-280000088941us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-280000088941us-gaap:ParentMember2024-01-280000088941us-gaap:NoncontrollingInterestMember2024-01-2800000889412024-01-280000088941us-gaap:RetainedEarningsMember2024-01-292024-04-280000088941us-gaap:ParentMember2024-01-292024-04-280000088941us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-292024-04-280000088941us-gaap:NoncontrollingInterestMember2024-01-292024-04-280000088941us-gaap:AdditionalPaidInCapitalMember2024-01-292024-04-280000088941us-gaap:CommonStockMember2024-01-292024-04-280000088941us-gaap:TreasuryStockCommonMember2024-01-292024-04-280000088941us-gaap:CommonStockMember2024-04-280000088941us-gaap:TreasuryStockCommonMember2024-04-280000088941us-gaap:AdditionalPaidInCapitalMember2024-04-280000088941us-gaap:RetainedEarningsMember2024-04-280000088941us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-280000088941us-gaap:ParentMember2024-04-280000088941us-gaap:NoncontrollingInterestMember2024-04-2800000889412024-04-280000088941smtc:ConvertibleSeniorNotesDue2027Memberus-gaap:ConvertibleDebtMember2025-01-272025-04-270000088941smtc:ConvertibleSeniorNotesDue2027Memberus-gaap:ConvertibleDebtMember2024-01-292024-04-280000088941smtc:ConvertibleSeniorNotesDue2028Memberus-gaap:ConvertibleDebtMember2025-01-272025-04-270000088941smtc:ConvertibleSeniorNotesDue2028Memberus-gaap:ConvertibleDebtMember2024-01-292024-04-280000088941us-gaap:StockCompensationPlanMember2025-01-272025-04-270000088941us-gaap:StockCompensationPlanMember2024-01-292024-04-280000088941us-gaap:WarrantMember2025-01-272025-04-270000088941us-gaap:WarrantMember2024-01-292024-04-280000088941us-gaap:CostOfSalesMember2025-01-272025-04-270000088941us-gaap:CostOfSalesMember2024-01-292024-04-280000088941smtc:ProductDevelopmentAndEngineeringMember2025-01-272025-04-270000088941smtc:ProductDevelopmentAndEngineeringMember2024-01-292024-04-280000088941us-gaap:SellingGeneralAndAdministrativeExpensesMember2025-01-272025-04-270000088941us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-01-292024-04-280000088941smtc:SettledWithSharesMembersmtc:EmployeeStockUnitAwardsMembersrt:MinimumMember2025-01-272025-04-270000088941smtc:SettledWithSharesMembersmtc:EmployeeStockUnitAwardsMembersrt:MaximumMember2025-01-272025-04-270000088941smtc:EmployeeStockUnitAwardsMembersmtc:SettledInCashMember2025-01-272025-04-270000088941smtc:SettledWithSharesMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:RestrictedStockUnitsRSUMember2025-01-272025-04-270000088941us-gaap:RestrictedStockUnitsRSUMembersmtc:NonEmployeeDirectorStockUnitAwardsMember2025-01-272025-04-270000088941us-gaap:RestrictedStockUnitsRSUMembersmtc:NonEmployeeDirectorStockUnitAwardsMember2025-04-270000088941us-gaap:RestrictedStockUnitsRSUMemberus-gaap:AccruedLiabilitiesMembersmtc:NonEmployeeDirectorStockUnitAwardsMember2025-04-270000088941us-gaap:RestrictedStockUnitsRSUMemberus-gaap:OtherNoncurrentLiabilitiesMembersmtc:NonEmployeeDirectorStockUnitAwardsMember2025-04-270000088941us-gaap:RestrictedStockUnitsRSUMembersmtc:NonEmployeeDirectorStockUnitAwardsMember2025-01-260000088941us-gaap:RestrictedStockUnitsRSUMemberus-gaap:AccruedLiabilitiesMembersmtc:NonEmployeeDirectorStockUnitAwardsMember2025-01-260000088941us-gaap:RestrictedStockUnitsRSUMemberus-gaap:OtherNoncurrentLiabilitiesMembersmtc:NonEmployeeDirectorStockUnitAwardsMember2025-01-260000088941smtc:FinancialMetricBasedRestrictedStockUnitsRSUsMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2025-01-272025-04-270000088941smtc:FinancialMetricBasedRestrictedStockUnitsRSUsMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2025-01-272025-04-270000088941smtc:FinancialMetricBasedRestrictedStockUnitsRSUsMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2025-01-272025-04-270000088941smtc:FinancialMetricBasedRestrictedStockUnitsRSUsMember2025-01-272025-04-270000088941smtc:FinancialMetricBasedRestrictedStockUnitsRSUsMembersrt:MaximumMembersrt:ScenarioForecastMember2026-01-250000088941us-gaap:ConvertibleDebtSecuritiesMember2025-04-270000088941us-gaap:ConvertibleDebtSecuritiesMember2025-01-260000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMember2025-04-270000088941us-gaap:FairValueInputsLevel1Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2025-04-270000088941us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2025-04-270000088941us-gaap:FairValueInputsLevel3Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2025-04-270000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMember2025-01-260000088941us-gaap:FairValueInputsLevel1Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2025-01-260000088941us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2025-01-260000088941us-gaap:FairValueInputsLevel3Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2025-01-260000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMember2025-04-270000088941us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMember2025-04-270000088941us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMember2025-04-270000088941us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMember2025-04-270000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMember2025-01-260000088941us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMember2025-01-260000088941us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMember2025-01-260000088941us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMember2025-01-260000088941us-gaap:FairValueMeasurementsRecurringMember2025-04-270000088941us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2025-04-270000088941us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2025-04-270000088941us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2025-04-270000088941us-gaap:FairValueMeasurementsRecurringMember2025-01-260000088941us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2025-01-260000088941us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2025-01-260000088941us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2025-01-260000088941smtc:ConvertibleSeniorNotesDue2027Memberus-gaap:ConvertibleDebtMember2025-04-270000088941smtc:ConvertibleSeniorNotesDue2027Memberus-gaap:ConvertibleDebtMember2025-01-260000088941smtc:ConvertibleSeniorNotesDue2028Memberus-gaap:ConvertibleDebtMember2025-04-270000088941smtc:ConvertibleSeniorNotesDue2028Memberus-gaap:ConvertibleDebtMember2025-01-260000088941us-gaap:ConvertibleDebtMember2025-04-270000088941us-gaap:ConvertibleDebtMember2025-01-260000088941us-gaap:OperatingSegmentsMembersmtc:SignalIntegrityProductsGroupMember2025-04-270000088941us-gaap:OperatingSegmentsMembersmtc:SignalIntegrityProductsGroupMember2025-01-260000088941us-gaap:OperatingSegmentsMembersmtc:AdvancedProtectionAndSensingProductsGroupMember2025-04-270000088941us-gaap:OperatingSegmentsMembersmtc:AdvancedProtectionAndSensingProductsGroupMember2025-01-260000088941us-gaap:OperatingSegmentsMembersmtc:IoTSystemMember2025-04-270000088941us-gaap:OperatingSegmentsMembersmtc:IoTSystemMember2025-01-260000088941us-gaap:OperatingSegmentsMembersmtc:SignalIntegrityProductsGroupMember2025-01-272025-04-270000088941us-gaap:OperatingSegmentsMembersmtc:AdvancedProtectionAndSensingProductsGroupMember2025-01-272025-04-270000088941us-gaap:OperatingSegmentsMembersmtc:IoTSystemMember2025-01-272025-04-270000088941us-gaap:DevelopedTechnologyRightsMembersrt:MinimumMember2025-04-270000088941us-gaap:DevelopedTechnologyRightsMembersrt:MaximumMember2025-04-270000088941us-gaap:DevelopedTechnologyRightsMember2025-04-270000088941us-gaap:CustomerRelationshipsMembersrt:MinimumMember2025-04-270000088941us-gaap:CustomerRelationshipsMembersrt:MaximumMember2025-04-270000088941us-gaap:CustomerRelationshipsMember2025-04-270000088941us-gaap:TradeNamesMembersrt:MinimumMember2025-04-270000088941us-gaap:TradeNamesMembersrt:MaximumMember2025-04-270000088941us-gaap:TradeNamesMember2025-04-270000088941smtc:CapitalizedDevelopmentCostsMember2025-04-270000088941us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2025-04-270000088941us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2025-01-260000088941us-gaap:DevelopedTechnologyRightsMember2025-01-260000088941us-gaap:CustomerRelationshipsMember2025-01-260000088941us-gaap:TradeNamesMember2025-01-260000088941smtc:CapitalizedDevelopmentCostsMember2025-01-260000088941us-gaap:DevelopedTechnologyRightsMember2025-01-272025-04-270000088941us-gaap:DevelopedTechnologyRightsMember2024-01-292024-04-280000088941us-gaap:CustomerRelationshipsMember2025-01-272025-04-270000088941us-gaap:CustomerRelationshipsMember2024-01-292024-04-280000088941us-gaap:TradeNamesMember2025-01-272025-04-270000088941us-gaap:TradeNamesMember2024-01-292024-04-280000088941smtc:CapitalizedDevelopmentCostsMember2025-01-272025-04-270000088941smtc:CapitalizedDevelopmentCostsMember2024-01-292024-04-280000088941us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2025-01-272025-04-270000088941us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2024-01-292024-04-280000088941us-gaap:InProcessResearchAndDevelopmentMember2025-01-260000088941us-gaap:InProcessResearchAndDevelopmentMember2025-01-272025-04-270000088941us-gaap:InProcessResearchAndDevelopmentMember2025-04-270000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMember2025-04-270000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMember2025-01-260000088941smtc:CreditAgreementMemberus-gaap:SecuredDebtMemberus-gaap:LineOfCreditMember2025-04-270000088941smtc:CreditAgreementMemberus-gaap:SecuredDebtMemberus-gaap:LineOfCreditMember2025-01-260000088941smtc:CreditAgreementMemberus-gaap:SecuredDebtMemberus-gaap:LineOfCreditMember2023-01-302023-04-300000088941smtc:CreditAgreementMemberus-gaap:SecuredDebtMemberus-gaap:LineOfCreditMember2023-04-300000088941smtc:TriggeringEventTwoMember2023-04-300000088941us-gaap:RevolvingCreditFacilityMember2025-01-272025-04-270000088941us-gaap:RevolvingCreditFacilityMember2025-04-270000088941smtc:TriggeringEventThreeMember2025-04-270000088941smtc:TriggeringEventThreeMember2025-01-272025-04-270000088941smtc:TriggeringEventTwoMember2025-01-260000088941us-gaap:RevolvingCreditFacilityMember2024-01-292025-01-260000088941us-gaap:RevolvingCreditFacilityMember2025-01-260000088941smtc:TriggeringEventThreeMember2025-01-260000088941smtc:TriggeringEventThreeMember2024-01-292025-01-260000088941smtc:CreditAgreementMaturesOnJanuary122028Memberus-gaap:RevolvingCreditFacilityMember2023-01-120000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMember2023-01-120000088941smtc:CreditAgreementMemberus-gaap:SecuredDebtMemberus-gaap:LineOfCreditMember2023-01-120000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMember2025-04-2400000889412024-01-292025-01-260000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMember2024-01-292025-01-260000088941smtc:CreditAgreementMemberus-gaap:LetterOfCreditMember2019-11-070000088941smtc:CreditAgreementMemberus-gaap:BridgeLoanMember2019-11-070000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMember2019-11-070000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMember2023-02-242023-02-240000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMember2023-02-242023-02-240000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMember2023-06-060000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMembersrt:MinimumMember2023-06-062023-06-060000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMembersrt:MaximumMember2023-06-062023-06-060000088941smtc:CreditAgreementFinancialCovenantReliefPeriodMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMembersrt:MinimumMember2023-06-062023-06-060000088941smtc:CreditAgreementMemberus-gaap:SecuredDebtMemberus-gaap:LineOfCreditMember2023-06-062023-06-060000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMembersmtc:DebtInstrumentOneMonthInterestPeriodMember2023-06-062023-06-060000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMembersmtc:DebtInstrumentThreeMonthInterestPeriodMember2023-06-062023-06-060000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMembersmtc:DebtInstrumentSixMonthInterestPeriodMember2023-06-062023-06-060000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MinimumMember2023-06-062023-06-060000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MaximumMember2023-06-062023-06-060000088941smtc:CreditAgreementFinancialCovenantReliefPeriodMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MinimumMember2023-06-062023-06-060000088941smtc:CreditAgreementMemberus-gaap:SecuredDebtMemberus-gaap:LineOfCreditMembersmtc:TriggeringEventTwoMember2023-06-060000088941smtc:CreditAgreementMemberus-gaap:SecuredDebtMemberus-gaap:LineOfCreditMembersmtc:TriggeringEventOneMember2023-06-060000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMembersmtc:TriggeringEventThreeMember2023-06-060000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMembersmtc:TriggeringEventFourMember2023-06-060000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMembersmtc:TriggeringEventFiveMember2023-06-060000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMembersmtc:TriggeringEventSixMember2023-06-060000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMembersmtc:TriggeringEventSevenMember2023-06-060000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMembersmtc:TriggeringEventEightMember2023-06-060000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMembersmtc:TriggeringEventNineMember2023-06-060000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMembersmtc:TriggeringEventTenMember2023-06-060000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMembersmtc:TriggeringEventElevenMember2023-06-060000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMembersmtc:TriggeringEventTwelveMember2023-06-060000088941smtc:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMembersmtc:TriggeringEventThirteenMember2023-06-060000088941smtc:CreditAgreementMemberus-gaap:SecuredDebtMemberus-gaap:LineOfCreditMember2022-10-312023-01-290000088941smtc:CreditAgreementMemberus-gaap:SecuredDebtMemberus-gaap:LineOfCreditMember2023-01-290000088941smtc:TriggeringEventTwoMember2023-01-290000088941smtc:ConvertibleSeniorNotesDue2027Memberus-gaap:ConvertibleDebtMember2022-10-120000088941smtc:ConvertibleSeniorNotesDue2027Memberus-gaap:ConvertibleDebtMember2022-10-210000088941smtc:DebtConversionTermsOneMembersmtc:ConvertibleSeniorNotesDue2028Memberus-gaap:ConvertibleDebtMember2022-10-212022-10-210000088941smtc:DebtConversionTermsOneMembersmtc:ConvertibleSeniorNotesDue2027Memberus-gaap:ConvertibleDebtMember2022-10-212022-10-210000088941smtc:DebtConversionTermsTwoMembersmtc:ConvertibleSeniorNotesDue2027Memberus-gaap:ConvertibleDebtMember2022-10-212022-10-210000088941smtc:ConvertibleSeniorNotesDue2027Memberus-gaap:ConvertibleDebtMember2022-10-1900000889412022-10-062022-10-1900000889412022-10-1900000889412022-10-060000088941smtc:ConvertibleSeniorNotesDue2028Memberus-gaap:ConvertibleDebtMember2023-10-260000088941smtc:DebtConversionTermsOneMembersmtc:ConvertibleSeniorNotesDue2028Memberus-gaap:ConvertibleDebtMember2023-10-262023-10-260000088941smtc:DebtConversionTermsTwoMembersmtc:ConvertibleSeniorNotesDue2028Memberus-gaap:ConvertibleDebtMember2023-10-262023-10-260000088941smtc:ConvertibleSeniorNotesDue2028Memberus-gaap:ConvertibleDebtMember2024-07-240000088941smtc:ConvertibleSeniorNotesDue2028Memberus-gaap:ConvertibleDebtMember2024-07-242024-07-240000088941us-gaap:LetterOfCreditMember2025-01-260000088941smtc:RevolvingLoansAndNonUsDollarsLcMember2025-04-270000088941smtc:SwinglineLoansMember2025-01-260000088941us-gaap:LetterOfCreditMember2025-04-270000088941smtc:RevolvingLoansAndNonUsDollarsLcMember2025-01-260000088941smtc:SwinglineLoansMember2025-04-270000088941smtc:ConvertibleSeniorNotesDue2027Memberus-gaap:ConvertibleDebtMember2022-10-212022-10-210000088941smtc:ConvertibleSeniorNotesDue2028Memberus-gaap:ConvertibleDebtMember2023-10-262023-10-260000088941smtc:NoncurrentdeferredtaxassetMember2025-04-270000088941smtc:NoncurrentdeferredtaxassetMember2025-01-260000088941us-gaap:OtherNoncurrentLiabilitiesMember2025-04-270000088941us-gaap:OtherNoncurrentLiabilitiesMember2025-01-260000088941smtc:SierraWirelessMembersmtc:HarmanBeckerAutomotiveSystemsGmbHMember2022-03-252022-03-250000088941us-gaap:EnvironmentalIssueMembersrt:MinimumMember2025-04-270000088941us-gaap:EnvironmentalIssueMembersrt:MaximumMember2025-04-270000088941us-gaap:EnvironmentalIssueMember2025-01-272025-04-270000088941us-gaap:EnvironmentalIssueMember2025-04-270000088941us-gaap:AccruedLiabilitiesMembersmtc:DeferredCompensationPlanForOfficersAndExecutivesMember2025-04-270000088941us-gaap:AccruedLiabilitiesMembersmtc:DeferredCompensationPlanForOfficersAndExecutivesMember2025-01-260000088941us-gaap:OtherNoncurrentLiabilitiesMembersmtc:DeferredCompensationPlanForOfficersAndExecutivesMember2025-04-270000088941us-gaap:OtherNoncurrentLiabilitiesMembersmtc:DeferredCompensationPlanForOfficersAndExecutivesMember2025-01-260000088941smtc:DeferredCompensationPlanForOfficersAndExecutivesMember2025-04-270000088941smtc:DeferredCompensationPlanForOfficersAndExecutivesMember2025-01-260000088941us-gaap:OtherAssetsMember2025-04-270000088941us-gaap:OtherAssetsMember2025-01-260000088941us-gaap:OneTimeTerminationBenefitsMember2025-01-260000088941us-gaap:ContractTerminationMember2025-01-260000088941us-gaap:OneTimeTerminationBenefitsMember2025-01-272025-04-270000088941us-gaap:ContractTerminationMember2025-01-272025-04-270000088941us-gaap:OneTimeTerminationBenefitsMember2025-04-270000088941us-gaap:ContractTerminationMember2025-04-270000088941smtc:CustomerAMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-272025-04-270000088941smtc:CustomerAMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-292024-04-280000088941smtc:CustomerBMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-292024-04-280000088941smtc:CustomerBMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2025-01-272025-04-270000088941smtc:CustomerCMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2025-01-272025-04-270000088941smtc:CustomerAMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2024-01-292025-01-260000088941smtc:CustomerDMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2024-01-292025-01-260000088941us-gaap:OperatingSegmentsMembersmtc:SignalIntegrityProductsGroupMember2025-01-272025-04-270000088941us-gaap:OperatingSegmentsMembersmtc:AdvancedProtectionAndSensingProductsGroupMember2025-01-272025-04-270000088941us-gaap:OperatingSegmentsMembersmtc:SemiconductorProductsGroupMember2025-01-272025-04-270000088941us-gaap:OperatingSegmentsMembersmtc:IoTSystemsAndConnectivityMember2025-01-272025-04-270000088941us-gaap:MaterialReconcilingItemsMember2025-01-272025-04-270000088941us-gaap:OperatingSegmentsMembersmtc:SignalIntegrityProductsGroupMember2024-01-292024-04-280000088941us-gaap:OperatingSegmentsMembersmtc:AdvancedProtectionAndSensingProductsGroupMember2024-01-292024-04-280000088941us-gaap:OperatingSegmentsMembersmtc:SemiconductorProductsGroupMember2024-01-292024-04-280000088941us-gaap:OperatingSegmentsMembersmtc:IoTSystemsAndConnectivityMember2024-01-292024-04-280000088941us-gaap:MaterialReconcilingItemsMember2024-01-292024-04-280000088941srt:AsiaPacificMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-272025-04-270000088941srt:AsiaPacificMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-292024-04-280000088941srt:NorthAmericaMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-272025-04-270000088941srt:NorthAmericaMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-292024-04-280000088941srt:EuropeMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-272025-04-270000088941srt:EuropeMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-292024-04-280000088941us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-272025-04-270000088941us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-292024-04-280000088941smtc:ChinaIncludingHongKongMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-272025-04-270000088941smtc:ChinaIncludingHongKongMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-292024-04-280000088941country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-272025-04-270000088941country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-292024-04-2800000889412021-03-112021-03-11

____________________________________

____________________________________

(Mark One)

____________________________________ 

 ____________________________________

____________________________________

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes   x   No  ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes   x   No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐   No  x 

Number of shares of common stock, $0.01 par value per share, outstanding at May 23, 2025: 86,635,593

INDEX TO FORM 10-Q

FOR THE QUARTER ENDED APRIL 27, 2025

 

Unless the context otherwise requires, the use of the terms "Semtech," the "Company," "we," "us" and "our" in this Quarterly Report on Form 10-Q refers to Semtech Corporation and, as applicable, its consolidated subsidiaries. This Quarterly Report on Form 10-Q may contain references to the Company's trademarks and to trademarks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this Quarterly Report on Form 10-Q, including logos, artwork and other visual displays, may appear without the ® or TM symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensor to these trademarks and trade names. We do not intend our use or display of other companies' trade names or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other company.

This Quarterly Report on Form 10-Q contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, as amended, based on our current expectations, estimates and projections about our operations, industry, financial condition, performance, results of operations, and liquidity. Forward-looking statements are statements other than historical information or statements of current condition and relate to matters such as future financial performance, future operational performance, the anticipated impact of specific items on future earnings, and our plans, objectives and expectations. Statements containing words such as "may," "believe," "see," "anticipate," "expect," "intend," "plan," "project," "objective," "estimate," "develop," "should," "could," "will," "designed to," "projections," or "outlook," or other similar expressions constitute forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties that could cause actual results and events to differ materially from those projected. Potential factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to: the volatility of the Company’s financial results or impact of the cyclical nature of the industry, including during industry downturns or due to periodic economic uncertainty; the historical rapid decrease of the average selling prices of certain products; disruptions in U.S. or foreign government operations, funding or incentives; changes in export restrictions and laws affecting the Company’s trade and investments, including tariffs or retaliatory tariffs; interruption or loss of supplies or services from the limited number of suppliers and subcontractors the Company relies upon; suppliers’ manufacturing capacity constraints or other supply chain disruptions; failure to successfully develop and sell new products, meet new industry standards or requirements or anticipate changes in projected or end market users; failure to adequately protect intellectual property rights; failure to make the substantial investments in research and development that are required to remain competitive in the Company’s business or to properly anticipate competitive changes in the marketplace; the likelihood of products being found defective or risk of liability claims asserted against the Company; business interruptions, such as natural disasters, acts of violence and the outbreak of contagious diseases; adverse changes to general economic conditions in China; the loss of any one of the Company’s small number of customers or failure to collect a receivable from them; competition from new or established internet of things ("IoT"), cloud services and wireless service companies or from those with greater resources; the difficulties associated with integrating the Company’s and Sierra Wireless, Inc.’s businesses and operations successfully as well as difficulties executing other acquisitions or divestitures; discovery of additional material weaknesses in the Company’s internal control over financial reporting in the future or otherwise failing to achieve and maintain effective disclosure controls, procedures and internal control over financial reporting; changes in the Company’s effective tax rates, the adoption of new U.S. or foreign tax legislation or exposure to additional tax liabilities, or material differences between the Company’s forecasted annual effective tax rates and actual tax rates; the Company’s ability to comply with, or pursue business strategies due to, the Company’s level of indebtedness or the covenants under the agreements governing its indebtedness; and adverse developments affecting the financial services industry. Additionally, forward-looking statements should be considered in conjunction with the cautionary statements contained in the Company’s Annual Report on Form 10-K for the fiscal year ended January 26, 2025 filed with the Securities and Exchange Commission (the "SEC") on March 25, 2025, including, without limitation, information under the captions "Management’s Discussion and Analysis of Financial Condition and Results of Operations" and those set forth under "Risk Factors" in Item 1A of the Company’s Annual Report on Form 10-K, as such risk factors may be amended, supplemented or superseded from time to time by other reports we file with SEC. In light of the significant risks and uncertainties inherent in the forward-looking information included herein that may cause actual performance and results to differ materially from those predicted, any such forward-looking information should not be regarded as representations or guarantees by the Company of future performance or results, or that its objectives or plans will be achieved, or that any of its operating expectations or financial forecasts will be realized. Reported results should not be considered an indication of future performance. Investors are cautioned not to place undue reliance on any forward-looking information contained herein, which reflect management’s analysis only as of the date hereof. These forward-looking statements speak only as of the date hereof. Except as required by law, the Company assumes no obligation to publicly release the results of any update or revision to any forward-looking statement that may be made to reflect new information, events or circumstances after the date hereof or to reflect the occurrence of unanticipated or future events, or otherwise.

 

ITEM 1.Financial Statements

(in thousands, except per share data)

(unaudited)

 

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(unaudited)

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share data)

(unaudited)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

(in thousands, except share data)

(unaudited)

(unaudited)

			Three Months Ended
			April 27, 2025						April 28, 2024
Cash flows from operating activities:
Net income (loss)			$	19,345					$	(23,159)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization			10,190						10,504
Amortization of right-of-use assets			1,346						1,431
Investment impairments and credit loss reserves, net			—						1,109
Accretion of deferred financing costs			1,254						2,379
Write-off of deferred financing costs			152						—
Interest rate swap termination			14						—
Deferred income taxes			2,411						(884)
Share-based compensation			6,835						15,234
Loss on disposition of business operations and assets			26						64
Equity method income			(1,046)						(50)
Gain from sale of investments			—						(277)
Corporate-owned life insurance, net			655						695
Changes in assets and liabilities:
Accounts receivable, net			(3,107)						(19,613)
Inventories			(6,627)						(3,632)
Other assets			2,281						13,610
Accounts payable			9,805						19,053
Accrued liabilities			(15,444)						(14,260)
Other liabilities			(266)						(2,293)
Net cash provided by (used in) operating activities			27,824						(89)
Cash flows from investing activities:
Purchase of property, plant and equipment			(1,650)						(1,334)
Proceeds from sale of investments			536						2,650
Purchase of intangibles			(529)						(1,326)
Proceeds from corporate-owned life insurance			—						1,801
Premiums paid for corporate-owned life insurance			(3,428)						—
Net cash (used in) provided by investing activities			(5,071)						1,791
Cash flows from financing activities:
Payments of term loans			(10,000)						—
Deferred financing costs			(492)						(824)
Payments for employee share-based compensation payroll taxes			(8,901)						(2,425)
Proceeds from exercise of stock options			32						235
Distributions to noncontrolling interest			—						(184)
Net cash used in financing activities			(19,361)						(3,198)
Effect of foreign exchange rate changes on cash and cash equivalents			1,339						(312)
Net increase (decrease) in cash and cash equivalents			4,731						(1,808)
Cash and cash equivalents at beginning of period			151,743						128,585
Cash and cash equivalents at end of period			$	156,474					$	126,777
Supplemental disclosure of cash flow information:
Interest paid			$	3,526					$	17,147
Income taxes paid			$	1,335					$	2,769
Non-cash investing and financing activities:
Accounts payable related to capital expenditures			$	247					$	331
Accrued deferred financing costs			$	72					$	—
Accrued purchases of intangibles			$	5,130					$	—

(Unaudited)

Semtech Corporation (together with its consolidated subsidiaries, the "Company" or "Semtech") is a leading provider of high-performance semiconductor, Internet of Things ("IoT") systems and cloud connectivity service solutions. The end customers for the Company's silicon solutions are primarily original equipment manufacturers that produce and sell technology solutions. The Company's IoT module, router, gateway (together "IoT Hardware") and managed connectivity solutions ship to IoT device makers and enterprises to provide IoT connectivity to end devices.

The Company designs, develops, manufactures and markets a diverse portfolio of products for commercial applications, addressing the global infrastructure, high-end consumer and industrial end markets.

The Company reports results on the basis of 52 and 53-week periods and ends its fiscal year on the last Sunday in January. The other quarters generally end on the last Sunday of April, July and October. All quarters consist of 13 weeks except for one 14-week period in the fourth quarter of 53-week years. The first quarter of fiscal years 2026 and 2025 each consisted of 13 weeks.

Certain reclassifications within the Statements of Operations (as defined and described below) have been made to prior period amounts to conform to current period presentation, with no impact to the Company's gross profit, operating income, net income or earnings per share for any historical periods and no impact to the Balance Sheets or Statements of Cash Flows (as defined and described below).

The accompanying interim unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP") and on the same basis as the audited consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended January 26, 2025 ("Annual Report"). The Company's interim unaudited condensed consolidated statements of operations are referred to herein as the "Statements of Operations," the Company's interim unaudited condensed consolidated balance sheets are referred to herein as the "Balance Sheets," and the Company's interim unaudited condensed consolidated statements of cash flows are referred to herein as the "Statements of Cash Flows." In the opinion of the Company, these interim unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly, in all material respects, the financial position and results of operations of the Company for the interim periods presented. All intercompany balances have been eliminated. Because the interim unaudited condensed consolidated financial statements do not include all of the information and notes required by GAAP for a complete set of consolidated financial statements, they should be read in conjunction with the audited consolidated financial statements and notes included in the Company's Annual Report. The results reported in these interim unaudited condensed consolidated financial statements should not be regarded as indicative of results that may be expected for any subsequent period or for the entire year.

The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

In November 2024, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2024-04, which clarifies the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. The amendments are effective for the Company for fiscal years beginning after December 15, 2025, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

In November 2024, the FASB issued ASU 2024-03, which requires public business entities to expand disclosures about specific expense categories. The amendments in this ASU require a public entity to disclose, in tabular format, in the notes to the financial statements, specific information about certain costs and expenses. Although the ASU does not change the expense captions an entity presents on the face of the income statement, it requires disaggregation of certain expense captions into specified categories. The amendments are effective for the Company for fiscal years beginning after December 15, 2026, with early adoption permitted.

The Company is currently evaluating the impact of this guidance on its disclosures within its consolidated financial statements.

In December 2023, the FASB issued ASU 2023-09, which requires public business entities to disclose sufficient information to enable users of financial statements to understand the nature and magnitude of factors contributing to the difference between the effective tax rate and the statutory tax rate. The amendments in this update provide that a business entity disclose (1) a tabular income tax rate reconciliation, using both percentages and amounts, (2) separate disclosure of any individual reconciling items that are equal to or greater than 5% of the amount computed by multiplying the income (loss) from continuing operations before income taxes by the applicable statutory income tax rate, and disaggregation of certain items that are significant and (3) amount of income taxes paid (net of refunds received) disaggregated by federal, state and foreign jurisdictions, including separate disclosure of any individual jurisdictions representing greater than 5% of total income taxes paid. The amendments are effective for the Company for fiscal years beginning after December 15, 2024. Early adoption is permitted and entities may apply the amendments prospectively or may elect retrospective application. The Company is currently evaluating the impact of this guidance on its disclosures within its consolidated financial statements.

The computation of basic and diluted earnings (loss) per share was as follows:

Basic earnings or loss per share is computed by dividing net income or loss available to common stockholders by the weighted-average number of shares of common stock outstanding during the reporting period. Diluted earnings or loss per share incorporates the incremental shares issuable, calculated using the treasury stock method, upon the assumed exercise of non-qualified stock options and the vesting of restricted stock units, market-condition restricted stock units and financial metric-based restricted stock units if certain conditions have been met, but excludes such incremental shares that would have an anti-dilutive effect. Due to the Company's net loss for the three months ended April 28, 2024, all shares underlying stock options and restricted stock units were considered anti-dilutive.

Any dilutive effect of the Warrants (as defined in Note 8, Long-Term Debt) is calculated using the treasury-stock method. For the three months ended April 27, 2025 and April 28, 2024, the Warrants were excluded from diluted shares outstanding because the exercise price exceeded the average market price of the Company's common stock for the reporting periods, and for the three months ended April 28, 2024, they were also excluded due to net loss.

Pre-tax share-based compensation was included in the Statements of Operations as follows:

The Company grants restricted stock units to certain employees of which a portion are expected to be settled with shares of the Company's common stock and a portion are expected to be settled in cash. The restricted stock units that are to be settled with shares are accounted for as equity. The grant date for these awards is equal to the measurement date and they are valued as of the measurement date, based on the fair value of the Company's common stock at the grant date, and recognized as share-based compensation expense over the requisite vesting period (typically between 1 and 4 years). The restricted stock units that are to be settled in cash are accounted for as liabilities and the value of the awards is re-measured at the end of each reporting period until settlement at the end of the requisite vesting period (typically 3 years). In the three months ended April 27, 2025, the Company granted to certain employees 415,939 restricted stock units that settle in shares with a weighted-average grant date fair value of $35.20.

The Company maintains a compensation program pursuant to which restricted stock units are granted to the Company's directors who are not employed by the Company or any of its subsidiaries. Under the Company's director compensation program in effect prior to the Company's 2025 annual meeting of stockholders, a portion of the restricted stock units granted under the program would be settled in cash and a portion would be settled in shares of the Company's common stock. Restricted stock units granted under the program in connection with and following the Company's 2025 annual meeting of stockholders will be settled in shares of the Company's common stock. Restricted stock units awarded under the program are generally scheduled to vest on the earlier of (i) one year after the grant date or (ii) the day immediately preceding the first annual meeting of the Company's stockholders following the grant. Restricted stock units awarded under the program that are to be settled in cash will, subject to vesting, be settled when the director who received the award separates from service. Restricted stock units awarded under the program that are to be settled in shares of stock will, subject to vesting, be settled promptly following vesting; provided that a director may elect to defer the settlement date to the director's separation from service pursuant to the Company's Director Deferred Compensation Plan. The Company did not grant any restricted stock unit awards to non-employee directors in the three months ended April 27, 2025.

The restricted stock units that are to be settled in cash are accounted for as liabilities. These awards are not typically settled until a non-employee director's separation from service. The value of both the unvested and vested but unsettled awards are re-measured at the end of each reporting period until settlement. In the three months ended April 27, 2025, $3.1 million was paid to settle the vesting of 48,718 cash-settled restricted stock unit awards upon the separation of service of a former director. As of April 27, 2025, the total number of vested, but unsettled, shares subject to cash-settled restricted stock unit awards was 157,983 and the liability associated with these awards was $4.9 million, of which $2.2 million was included in "Accrued liabilities" in the Balance Sheets relating to two previous non-employee directors currently serving short-term non-employee consultancies for the Company. The remaining $2.7 million was included in "Other long-term liabilities" in the Balance Sheets as of April 27, 2025. As of January 26, 2025, the total number of vested, but unsettled, shares subject to cash-settled restricted stock unit awards was 206,701 and the liability associated with these awards was $14.5 million, of which $8.3 million was included in "Accrued liabilities" in the Balance Sheets relating to two previous non-employee directors currently serving short-term non-employee consultancies for the Company and one former non-employee director who separated from service. The remaining $6.2 million was included in "Other long-term liabilities" in the Balance Sheets as of January 26, 2025.

The Company grants financial metric-based restricted stock units with a market condition (the "Performance Awards") to certain executives of the Company, which are settled in shares and accounted for as equity awards. The Performance Awards have both a financial metric-based performance condition and a pre-defined market condition, which together determine the number of shares that ultimately vest, in addition to the condition of continued service. The number of vested shares for each of the three tranches of the awards, which are the one, two and three-year performance periods, is determined based on the Company's attainment of pre-established revenue and non-GAAP operating income targets for the respective performance period.

The vesting for tranches after the initial performance period is dependent on revenue and non-GAAP operating income for the preceding performance period. The market condition is determined based upon the Company's total stockholder return ("TSR") benchmarked against the TSR of an index over the three-year performance period. For fiscal year 2026 grants, the benchmark was against the Russell 3000 Index. The market condition functions as a catch-up provision in determining the vesting of the third tranche of the awards based on the performance over the full three-year performance period. Generally, the award recipients must be employed for the entire performance period and be an active employee at the time of vesting of the awards.

The grant-date fair values of the first and second tranches of the Performance Awards are valued using the closing stock price on the grant date and the grant-date fair value of the third tranche of the Performance Awards is valued using a Monte Carlo simulation, which takes into consideration the possible outcomes pertaining to the TSR market condition. The compensation cost of the Performance Awards is recognized using the accelerated attribution method over the requisite service period based on the number of shares that are probable of attainment for each fiscal year.

In the three months ended April 27, 2025, the Company granted 327,330 Performance Awards. The weighted-average grant-date fair values for each of the one, two and three-year performance periods over which the Performance Awards vest were $32.33, $32.33 and $40.78, respectively. Under the terms of these awards, assuming the highest performance level of 200% with no cancellations due to forfeitures, the maximum potential number of shares that can be earned in aggregate for the cumulative fiscal years 2026, 2027 and 2028 performance periods would be 654,660 shares. In the three months ended April 27, 2025, 27,073 Performance Awards were forfeited due to the terminations of certain officers.

The following table summarizes the values of the Company's available-for-sale securities:

The following table summarizes the maturities of the Company's available-for-sale securities:

The Company's available-for-sale securities consist of investments in convertible debt instruments issued by privately-held companies and are recorded at fair value. See Note 5, Fair Value Measurements, for further discussion of the valuation of the available-for-sale securities. The available-for-sale securities with maturities within one year are included in "Other current assets". Unrealized gains or losses, net of tax, are recorded in "Accumulated other comprehensive loss, net" in the Balance Sheets, and realized gains or losses, as well as current expected credit loss reserves were recorded in "Non-operating expense, net" in the Statements of Operations.

The following fair value hierarchy is applied for disclosure of the inputs used to measure fair value and prioritizes the inputs into three levels as follows:

Level 1—Quoted prices in active markets for identical assets or liabilities.

Level 2—Observable inputs other than Level 1 prices, such as quoted prices for similar assets and liabilities in active markets or other inputs that are observable for the assets or liabilities, either directly or indirectly.

Level 3—Unobservable inputs based on the Company's own assumptions, requiring significant management judgment or estimation.

The Company does not have any financial liabilities measured and recorded at fair value. The fair values of financial assets measured and recorded at fair value on a recurring basis were presented in the Balance Sheets as follows:

During the three months ended April 27, 2025, the Company had no transfers of financial assets between Level 1, Level 2 or Level 3. As of April 27, 2025 and January 26, 2025, the Company had not elected the fair value option for any financial assets for which such an election would have been permitted.

The convertible debt investments are valued utilizing a combination of estimates that are based on the estimated discounted cash flows associated with the debt and the fair value of the equity into which the debt may be converted, all of which are Level 3 inputs.

There were no changes in convertible debt investments in the three months ended April 27, 2025.

The interest rate swap agreements are measured at fair value using readily available interest rate curves (Level 2 inputs). The fair value of each agreement is determined by comparing, for each settlement, the contract rate to the forward rate and discounting to the present value. Contracts in a gain position are recorded in "Other current assets" and "Other assets" in the Balance Sheets and the value of contracts in a loss position are recorded in "Accrued liabilities" and "Other long-term liabilities" in the Balance Sheets.

See Note 16, Derivatives and Hedging Activities, for further discussion of the Company's derivative instruments.

Some of the Company's financial instruments are not measured at fair value, but are recorded at amounts that approximate fair value due to their liquid or short-term nature. Such financial assets and financial liabilities include: cash and cash equivalents including money market deposits, net receivables, certain other assets, accounts payable, accrued expenses, accrued personnel costs, and other current liabilities. The Company's revolving loans and Term Loans (as defined in Note 8, Long-Term Debt) are recorded at cost, which approximates fair value as the debt instruments bear interest at a floating rate. The 2027 Notes and 2028 Notes (as defined in Note 8, Long-Term Debt) are carried at face value less unamortized debt issuance costs, with interest expense reflecting the cash coupon plus the amortization of the capitalized issuance costs. The estimated fair values are determined based on the actual bid prices of the 2027 Notes and 2028 Notes as of the last business day of the period.

The following table displays the carrying values and fair values of the 2027 Notes and 2028 Notes:

(1) The 1.625% convertible senior notes due 2027, net, are reflected net of $5.9 million and $6.5 million of unamortized debt issuance costs as of April 27, 2025 and January 26, 2025, respectively.

(2) The 4.00% convertible senior notes due 2028, net, are reflected net of $1.5 million and $1.6 million of unamortized debt issuance costs as of April 27, 2025 and January 26, 2025, respectively.

The Company reduces the carrying amounts of its intangible assets, long-lived assets and non-marketable equity securities to fair value when it determines they are impaired.

The total credit loss reserve for the Company's held-to-maturity debt securities and available-for-sale debt securities remained flat at $4.5 million as of April 27, 2025 and January 26, 2025. Credit loss reserves related to the Company's available-for-sale debt securities and held-to-maturity debt securities with maturities within one year are included in "Other current assets" in the Balance Sheets.

Inventories, consisting of material, material overhead, labor, and manufacturing overhead, are stated at the lower of cost (first-in, first-out) or net realizable value and consisted of the following:

The following table summarizes goodwill by applicable operating segments:

The following table summarizes the change in goodwill by applicable operating segments:

Goodwill is not amortized, but is tested for impairment at the reporting unit level using either a qualitative or quantitative assessment on an annual basis during the fourth quarter of each fiscal year, and whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Impairment of goodwill is measured at the reporting unit level by comparing the reporting unit’s carrying amount, including goodwill, to the fair market value of the reporting unit. As of April 27, 2025, there was no indication of impairment of the Company's goodwill balances.

The following table sets forth the Company's finite-lived intangible assets, which are amortized over their estimated useful lives:

Amortization expense of finite-lived intangible assets was as follows:

Amortization expense of finite-lived intangible assets related to core technologies was recorded in "Amortization of acquired technology" within "Total cost of sales" in the Statements of Operations, and amortization expense of finite-lived intangible assets related to customer relationships and trade name was recorded in "Intangible amortization" within "Total operating expenses, net" in the Statements of Operations. Amortization expense of finite-lived intangible assets related to software licenses was recorded in "Cost of sales" in the Statements of Operations and amortization expense of finite-lived intangible assets related to capitalized development costs was recorded in "Product development and engineering" in the Statements of Operations.

Future amortization expense of finite-lived intangible assets is expected as follows:

Also in "Other intangible assets, net" in the Balance Sheets, are finite-lived intangible assets to be amortized upon placement in service. The following table sets forth the Company's finite-lived intangible assets not yet placed in service:

Long-term debt and the current period interest rates were as follows:

(1) The revolving loans and Term Loans (as defined below) bear interest at variable rates based on Adjusted Term SOFR or a Base Rate (as defined in the Credit Agreement), at the Company’s option, plus an applicable margin that varies based on the Company's consolidated leverage ratio. In the first quarter of fiscal year 2024, the Company entered into an interest rate swap agreement with a 2.75 year term to hedge the variability of interest payments on $150.0 million of debt outstanding on the Term Loans at a fixed Term SOFR rate of 3.58%, plus a variable margin and spread based on the Company’s consolidated leverage ratio. As of April 27, 2025, the effective interest rate was a weighted-average rate that represented (a) interest on $150.0 million of the debt outstanding on the Term Loans at a fixed SOFR rate of 3.58% plus a margin and spread of 1.85% (total fixed rate of 5.43%), (b) interest on the remaining debt outstanding on the Term Loans at a floating SOFR rate of 4.32% plus a margin and spread of 1.85% (total floating rate of 6.17%), (c) interest on the 2027 Notes outstanding at a fixed rate of 1.625%, and (d) interest on the 2028 Notes outstanding at a fixed rate of 4.00%. As of January 26, 2025, the effective interest rate was a weighted average-rate that represented (a) interest on $150.0 million of the debt outstanding on the Term Loans at a fixed SOFR rate of 3.58% plus a margin and spread of 3.85% (total fixed rate of 7.43%), (b) interest on the remaining debt outstanding on the Term Loans at a floating SOFR rate of 4.36% plus a margin and spread of 3.85% (total floating rate of 8.21%),(c) interest on the 2027 Notes outstanding at a fixed rate of 1.625%, and (d) interest on the 2028 Notes outstanding at a fixed rate of 4.00%.

On November 7, 2019, we, with certain of our domestic subsidiaries as guarantors, entered into a credit agreement with the lenders party thereto and HSBC Bank USA, National Association ("HSBC Bank"), as administrative agent, swing line lender and letter of credit issuer. On September 26, 2022 (the "Third Restatement Effective Date"), the Company entered into a third amended and restated credit agreement (as amended, restated, supplemented or otherwise modified from time to time, the "Credit Agreement") with the lenders party thereto, HSBC Bank, as resigning administrative agent, and JPMorgan Chase Bank, N.A. ("JPM"), as successor administrative agent, swing line lender and letter of credit issuer. The restated Credit Agreement, which was entered into substantially concurrently with the completion of the acquisition of Sierra Wireless, Inc. on January 12, 2023 (the "Sierra Wireless Acquisition") was entered into to, among other things, (i) extend the maturity date of $405.0 million of the $600.0 million in aggregate principal amount of revolving commitments thereunder from November 7, 2024 to January 12, 2028, (ii) provide for incurrence by the Company on January 12, 2023 of term loans (the "Term Loans") in an aggregate principal amount of $895.0 million, which was used to fund a portion of the cash consideration for the Sierra Wireless Acquisition, (iii) provide for JPM to succeed HSBC Bank as administrative agent and collateral agent under the Credit Agreement on January 12, 2023, (iv) modify the maximum consolidated leverage covenant as set forth in the Credit Agreement, (v) replace LIBOR with adjusted term SOFR and (vi) make certain other changes as set forth in the restated Credit Agreement, including changes consequential to the incorporation of the Term Loan Facility.

After effectiveness of the Fourth Amendment (as defined and described below), the borrowing capacity on the revolving credit facility under the Credit Agreement (the "Revolving Credit Facility") is $455.0 million, which is scheduled to mature on January 12, 2028 (subject to, in certain circumstances, an earlier springing maturity), and the term loans thereunder (the "Term Loans") are scheduled to mature on January 12, 2028 (subject to, in certain circumstances, an earlier springing maturity).

In fiscal year 2025, the Company repaid the outstanding amount of $68.3 million on the Revolving Credit Facility which matured on November 7, 2024 by borrowing against the remaining Revolving Credit Facility scheduled to mature on January 12, 2028. In fiscal 2025, the Company repaid an additional $215.0 million on the Revolving Credit Facility and repaid $441.4 million on the Term Loans.

In the first quarter of fiscal year 2026, the Company made an early repayment of $10.0 million on the Term Loans.

Up to $40.0 million of the Revolving Credit Facility may be used to obtain letters of credit, up to $25.0 million of the Revolving Credit Facility may be used to obtain swing line loans, and up to $75.0 million of the Revolving Credit Facility may be used to obtain revolving loans and letters of credit in certain currencies other than U.S. Dollars ("Alternative Currencies"). The proceeds of the Revolving Credit Facility may be used by the Company for capital expenditures, permitted acquisitions, permitted dividends, working capital and general corporate purposes.

On February 24, 2023, the Company entered into the first amendment (the "First Amendment") to the Credit Agreement, in order to, among other things, (i) increase the maximum consolidated leverage ratio covenant for certain test periods as set forth therein, (ii) reduce the minimum consolidated interest coverage ratio covenant for certain test periods as set forth therein, (iii) provide that, during the period that financial covenant relief pursuant to the First Amendment is in effect, the interest rate margin for (1) Term SOFR loans is deemed to be 2.50% and (2) Base Rate (as defined in the Credit Agreement) loans is deemed to be 1.50% per annum and (iv) make certain other changes as set forth therein.

On June 6, 2023, the Company entered into the second amendment (the "Second Amendment") to the Credit Agreement, in order to, among other things, (i) increase the maximum consolidated leverage ratio covenant for certain test periods as set forth therein and described below, (ii) reduce the minimum consolidated interest coverage ratio covenant for certain test periods as set forth therein and described below, (iii) modify the pricing grid applicable to loans under the Credit Agreement during the covenant relief period as set forth therein and described below, (iv) impose a minimum liquidity covenant for certain periods during the covenant relief period as set forth therein and described below, (v) increase the annual amortization in respect of the term loans thereunder to 7.5% per annum for certain periods as set forth therein, (vi) impose an "anti-cash hoarding" condition to the borrowing of revolving loans as set forth therein, (vii) provide that the maturity date for the Term Loans and revolving loans shall be the day that is 91 days prior to the stated maturity date of the 2027 Notes and the 2028 Notes if such notes have not otherwise been refinanced or extended to at least 91 days after the stated maturity date of the Term Loans and revolving loans, the aggregate principal amount of non-extended outstanding 2027 Notes and 2028 Notes and certain replacement debt exceeds $50 million and a minimum liquidity condition is not satisfied, (viii) provide for the reduction of the aggregate revolving commitments thereunder by $100 million, (ix) require that the Company appoint a financial advisor and (x) make certain other modifications to the mandatory prepayments (including the imposition of an excess cash flow mandatory prepayment), collateral provisions and covenants (including additional limitations on debt, liens, investments and restricted payments such as dividends) as set forth therein.

Effective June 6, 2023, in connection with the Second Amendment, interest on loans made under the Credit Agreement in U.S. Dollars accrues, at the Company's option, at a rate per annum equal to (1) (x) the Base Rate (as defined in the Credit Agreement) plus (y) a margin ranging from 0.25% to 2.75% depending upon the Company's consolidated leverage ratio (except that, during the period that financial covenant relief is in effect (including during the extended covenant relief period provided pursuant to the Third Amendment), the margin will not be less than 2.25% per annum) or (2) (x) Term SOFR Rate (as defined in the Credit Agreement) plus (y) a credit spread adjustment of (i) for term loans, 0.10% and (ii) for revolving credit borrowings, 0.11%, 0.26% or 0.43% for one, three and six month interest periods, respectively, plus (z) a margin ranging from 1.25% to 3.75% depending upon the Company's consolidated leverage ratio (except that, during the period that financial covenant relief pursuant to the Third Amendment is in effect, the margin will not be less than 3.25% per annum) (such margin, the "Applicable Margin"). Interest on loans made under the Revolving Credit Facility in Alternative Currencies accrues at a rate per annum equal to a customary benchmark rate (including, in certain cases, credit spread adjustments) plus the Applicable Margin.

On October 19, 2023, the Company entered into the third amendment (the "Third Amendment") to the Credit Agreement, in order to, among other things, (i) extend the financial covenant relief period by one year to April 30, 2026, (ii) increase the maximum consolidated leverage ratio covenant for certain test periods as set forth in the Third Amendment, (iii) reduce the minimum consolidated interest coverage ratio covenant for certain test periods as set forth in the Third Amendment and (iv) make certain other changes as set forth therein. These amendments had the effect of extending and temporarily expanding financial covenant relief under the Credit Agreement previously provided for in the First Amendment and Second Amendment.

On April 24, 2025, the Company entered into the fourth amendment (the "Fourth Amendment") to the Credit Agreement, in order to, among other things, increase the total available borrowing capacity under the revolving credit facility by $117.5 million increasing the total facility size to $455.0 million. Other than the foregoing, the material terms of the Credit Agreement remain unchanged.

All of the Company's obligations under the Credit Agreement are unconditionally guaranteed by all of the Company's direct and indirect domestic subsidiaries, other than certain excluded subsidiaries, including, but not limited to, any domestic subsidiary the primary assets of which consist of equity or debt of non-U.S. subsidiaries, certain immaterial non-wholly-owned domestic subsidiaries and subsidiaries that are prohibited from providing a guarantee under applicable law or that would require governmental approval to provide such guarantee. The Company and the guarantors have also pledged substantially all of their assets to secure their obligations under the Credit Agreement.

No amortization is required with respect to the revolving loans. Effective June 6, 2023, in connection with the Second Amendment, the Term Loans amortize (x) during the period that financial covenant relief is in effect (including during the extended covenant relief period provided pursuant to the Third Amendment), in equal quarterly installments of 1.875% of the aggregate principal amount outstanding on the Third Restatement Effective Date, and (y) otherwise, in equal quarterly installments of 1.25% of the aggregate principal amount outstanding on the Third Restatement Effective Date, with the balance due at maturity. The Company may voluntarily prepay borrowings at any time and from time to time, without premium or penalty, other than customary "breakage costs" in certain circumstances. In the third quarter of fiscal year 2024, the Company made a $250 million prepayment on the Term Loans in connection with the Third Amendment, after which there is no scheduled amortization remaining on the Term Loans.

The Credit Agreement contains customary representation and warranties, and affirmative and negative covenants, including limitations on the Company's ability to, among other things, incur indebtedness, create liens on assets, engage in certain fundamental corporate changes, make investments, repurchase stock, pay dividends or make similar distributions, engage in certain affiliate transactions, or enter into agreements that restrict the Company's ability to create liens, pay dividends or make loan repayments. In addition, the Company must comply with financial covenants which, after effectiveness of the Third Amendment are as follows (in each case, during the covenant relief period):

•maintaining a maximum consolidated leverage ratio, determined as of the last day of each fiscal quarter, of (i) 8.17 to 1.00 for the fiscal quarter ending on or around October 31, 2023, (ii) 10.27 to 1.00 for the fiscal quarter ending on or around January 31, 2024, (iii) 10.21 to 1.00 for the fiscal quarter ending on or around April 30, 2024, (iv) 9.93 to 1.00 for the fiscal quarter ending on or around July 31, 2024, (v) 8.42 to 1.00 for the fiscal quarter ending on or around October 31, 2024, (vi) 7.68 to 1.00 for the fiscal quarter ending on or around January 31, 2025, (vii) ) 6.75 to 1.00 for the fiscal quarter ending on or around April 30, 2025, (viii) 6.28 to 1.00 for the fiscal quarter ending on or around July 31, 2025, (ix) 5.81 to 1.00 for the fiscal quarter ending on or around October 31, 2025, (x) 5.30 to 1.00 for the fiscal quarter ending on or around January 31, 2026, and (xi) 3.75 to 1.00 for the fiscal quarter ending on or around April 30, 2026 and each fiscal quarter thereafter, subject to increase to 4.25 to 1.00 for the four full consecutive fiscal quarters ending on or after the date of consummation of a permitted acquisition that constitutes a "Material Acquisition" under the Credit Agreement, subject to the satisfaction of certain conditions;

•maintaining a minimum consolidated interest expense coverage ratio, determined as of the last day of each fiscal quarter, of (i) 1.66 to 1.00 for the fiscal quarter ending on or around October 31, 2023, (ii) 1.40 to 1.00 for the fiscal quarter ending on or around January 31, 2024, (iii) 1.37 to 1.00 for the fiscal quarter ending on or around April 30, 2024, (iv) 1.41 to 1.00 for the fiscal quarter ending on or around July 31, 2024, (v) 1.73 to 1.00 for the fiscal quarter ending on or around October 31, 2024, (vi) 1.90 to 1.00 for the fiscal quarter ending on or around January 31, 2025, (vii) 2.14 to 1.00 for the fiscal quarter ending on or around April 30, 2025, (viii) 2.37 to 1.00 for the fiscal quarter ending on or around July 31, 2025, (ix) 2.68 to 1.00 for the fiscal quarter ending on or around October 31, 2025, (x) 3.01 to 1.00 for the fiscal quarter ending on or around January 31, 2026, and (xi) 3.50 to 1.00 for the fiscal quarter ending on or around April 30, 2026 and each fiscal quarter thereafter; and

•until January 31, 2025, maintaining a minimum consolidated liquidity (as further defined in the Credit Agreement but excluding revolving credit commitments scheduled to expire in 2024) of $150 million as of the last day of each monthly accounting period of the Company.

Upon the termination of the covenant relief period under the Third Amendment, the ratio levels set forth above with respect to the leverage and interest expense coverage financial covenants are subject to step-up as set forth in the Credit Agreement, and the liquidity covenant shall no longer apply.

Compliance with the leverage and interest expense coverage financial covenants is measured quarterly based upon the Company's performance over the most recent four quarters, and compliance with the liquidity covenant is measured as of the last day of each monthly accounting period. As of April 27, 2025, the Company was in compliance with the financial covenants in the Credit Agreement.

The Credit Agreement also contains customary provisions pertaining to events of default. If any event of default occurs, the obligations under the Credit Agreement may be declared due and payable, terminated upon written notice to us and existing letters of credit may be required to be cash collateralized.

On October 12, 2022 and October 21, 2022, the Company issued and sold $300.0 million and $19.5 million, respectively, in aggregate principal amount of 1.625% Convertible Senior Notes due 2027 (the "2027 Notes") in a private placement. The 2027 Notes were issued pursuant to an indenture, dated October 12, 2022, by and among the Company, the subsidiary guarantors party thereto and U.S. Bank Trust Company, National Association, as trustee (the "2027 Indenture"). The 2027 Notes are jointly and severally and fully and unconditionally guaranteed by each of the Company's current and future direct and indirect wholly-owned domestic subsidiaries that guarantee its borrowings under its Credit Agreement. The 2027 Notes bear interest at a rate of 1.625% per year, payable semi-annually in arrears on May 1 and November 1 of each year, beginning on May 1, 2023. The 2027 Notes will mature on November 1, 2027, unless earlier converted, redeemed or repurchased.

The initial conversion rate of the 2027 Notes is 26.8325 shares of the Company's common stock per $1,000 principal amount of 2027 Notes (which is equivalent to an initial conversion price of approximately $37.27 per share). The conversion rate is subject to adjustment upon the occurrence of certain events specified in the 2027 Indenture but will not be adjusted for accrued and unpaid interest. In addition, upon the occurrence of a Make-Whole Fundamental Change (as defined in the 2027 Indenture) or if the Company delivers a Notice of Sale Price Redemption (as defined in the 2027 Indenture), the Company will, in certain circumstances, increase the conversion rate by a number of additional shares of common stock as described in the 2027 Indenture for a holder who elects to convert its 2027 Notes in connection with such Make-Whole Fundamental Change or to convert its 2027 Notes called (or deemed called as provided in the 2027 Indenture) for redemption in connection with such Notice of Sale Price Redemption, as the case may be.

Prior to the close of business on the business day immediately preceding July 1, 2027, the 2027 Notes are convertible at the option of the holders thereof only under the following circumstances: (1) during any fiscal quarter commencing after the fiscal quarter ended on January 29, 2023 (and only during such fiscal quarter), if the last reported sale price of the Company's common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period after any ten consecutive trading day period in which, for each trading day of that period, the Trading Price (as defined in the 2027 Indenture), as determined following a request by a holder of the 2027 Notes in accordance with the procedures described in the 2027 Indenture, per $1,000 principal amount of the 2027 Notes for such trading day was less than 98% of the product of the last reported sale price of the Company's common stock and the conversion rate on each such trading day; (3) if the Company calls such 2027 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, but only with respect to the 2027 Notes called (or deemed called as provided in the 2027 Indenture) for redemption; or (4) upon the occurrence of specified corporate events described in the 2027 Indenture. As of April 27, 2025, none of the conditions allowing holders of the 2027 Notes to convert had been met. On or after July 1, 2027 until the close of business on the second scheduled trading day immediately preceding the maturity date of the 2027 Notes, holders of the 2027 Notes may convert all or a portion of their 2027 Notes, regardless of the foregoing conditions. Upon conversion, the 2027 Notes will be settled in cash up to the aggregate principal amount of the 2027 Notes to be converted, and in cash, shares of the Company's common stock or any combination thereof, at the Company's option, in respect of the remainder, if any, of the Company's conversion obligation in excess of the aggregate principal amount of the 2027 Notes being converted.

The Company may not redeem the 2027 Notes prior to November 5, 2025. The Company may redeem for cash all or any portion of the 2027 Notes (subject to the limitation described below), at the Company's option, on or after November 5, 2025 and before the 61st scheduled trading day immediately preceding the maturity date if the last reported sale price of the Company's common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides the related notice of sale price redemption, at a redemption price equal to 100% of the principal amount of the 2027 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company redeems less than all the outstanding 2027 Notes, at least $75.0 million aggregate principal amount of the 2027 Notes must be outstanding and not subject to redemption as of the relevant redemption notice date. No sinking fund is provided for the 2027 Notes.

Upon the occurrence of a Fundamental Change (as defined in the 2027 Indenture) prior to the maturity date of the 2027 Notes, holders of the 2027 Notes may require the Company to repurchase all or a portion of the 2027 Notes for cash at a price equal to 100% of the principal amount of the 2027 Notes to be repurchased, plus any accrued and unpaid interest to, but excluding, the Fundamental Change Repurchase Date (as defined in the 2027 Indenture).

On October 6, 2022 and October 19, 2022, the Company entered into privately negotiated convertible note hedge transactions (the "Convertible Note Hedge Transactions") with an affiliate of one of the initial purchasers of the 2027 Notes and another financial institution (collectively, the "Counterparties") whereby the Company has the option to purchase the same number of shares of the Company's common stock initially underlying the 2027 Notes in the aggregate for approximately $37.27 per share, which is subject to anti-dilution adjustments substantially similar to those in the 2027 Notes.

The Convertible Note Hedge Transactions will expire upon the maturity of the 2027 Notes, if not earlier exercised. The Convertible Note Hedge Transactions are expected to reduce the potential dilution to the common stock upon the conversion of the 2027 Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of converted 2027 Notes, as the case may be, in the event that the market price per share of common stock, as measured under the terms of the Convertible Note Hedge Transactions, is greater than the strike price of the Convertible Note Hedge Transactions, which initially corresponds to the initial conversion price of the 2027 Notes, or approximately $37.27 per share of the common stock. The Convertible Note Hedge Transactions are separate transactions, entered into by the Company with each of the Counterparties, and are not part of the terms of the 2027 Notes. Holders of the 2027 Notes do not have any rights with respect to the Convertible Note Hedge Transactions. The Company used approximately $72.6 million of the net proceeds from the offering of the 2027 Notes to pay the cost of the Convertible Note Hedge Transactions. The Convertible Note Hedge Transactions are recorded in additional paid-in capital in the Balance Sheets as they do not require classification outside of equity pursuant to Accounting Standards Codification ("ASC") 480 and qualify for equity classification pursuant to ASC 815.

On October 6, 2022 and on October 19, 2022, the Company separately entered into privately negotiated warrant transactions (the "Warrants") with the Counterparties whereby the holders of the Warrants have the option to acquire, collectively, subject to anti-dilution adjustments, approximately 8.6 million shares of the Company's common stock at an initial strike price of approximately $51.15 per share. The Warrants were sold in private placements to the Counterparties pursuant to an exemption from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"), afforded by Section 4(a)(2) of the Securities Act. If the market price per share of the common stock, as measured under the terms of the Warrants, exceeds the strike price of the Warrants, the Warrants could have a dilutive effect on the common stock, unless the Company elects, subject to certain conditions, to settle the Warrants in cash. The Warrants will expire over a period beginning in February 2028.

The Warrants are separate transactions, entered into by the Company with each of the Counterparties, and are not part of the terms of the 2027 Notes. Holders of the 2027 Notes do not have any rights with respect to the Warrants. The Company received aggregate proceeds of approximately $42.9 million from the sale of the Warrants to the Counterparties. The Warrants are recorded in additional paid-in capital in the Balance Sheets as they do not require classification outside of equity pursuant to ASC 480 and qualify for equity classification pursuant to ASC 815.

In combination, the Convertible Note Hedge Transactions and the Warrants are intended to synthetically increase the strike price of the conversion option of the 2027 Notes from approximately $37.27 to $51.15 (subject to adjustment in accordance with the terms of the agreements governing such transactions), with the expected result of reducing the dilutive effect of the 2027 Notes in exchange for a net cash premium of $29.7 million.

On October 26, 2023, the Company issued and sold $250.0 million in aggregate principal amount of 4.00% Convertible Senior Notes due 2028 (the "2028 Notes") in a private placement. The 2028 Notes were issued pursuant to an indenture, dated October 26, 2023, by and among the Company, the subsidiary guarantors party thereto and U.S. Bank Trust Company, National Association, as trustee (the "2028 Indenture"). The 2028 Notes are jointly and severally and fully and unconditionally guaranteed by each of the Company's current and future direct and indirect wholly-owned domestic subsidiaries that guarantee its borrowings under its Credit Agreement. The 2028 Notes bear interest at a rate of 4.00% per year, payable semi-annually in arrears on May 1 and November 1 of each year, beginning on May 1, 2024. The 2028 Notes will mature on November 1, 2028, unless earlier converted, redeemed or repurchased. As of April 27, 2025, approximately $62.0 million of the 2028 Notes remained outstanding.

The initial conversion rate of the 2028 Notes is 49.0810 shares of the Company's common stock per $1,000 principal amount of 2028 Notes (which is equivalent to an initial conversion price of approximately $20.37 per share). The conversion rate is subject to adjustment upon the occurrence of certain events specified in the 2028 Indenture but will not be adjusted for accrued and unpaid interest. In addition, upon the occurrence of a Make-Whole Fundamental Change (as defined in the 2028 Indenture) or if the Company delivers a Notice of Redemption (as defined in the 2028 Indenture), the Company will, in certain circumstances, increase the conversion rate by a number of additional shares of common stock as described in the 2028 Indenture for a holder who elects to convert its 2028 Notes in connection with such Make-Whole Fundamental Change or to convert its 2028 Notes called (or deemed called as provided in the 2028 Indenture) for redemption in connection with such Notice of Redemption, as the case may be.

Prior to the close of business on the business day immediately preceding August 1, 2028, the 2028 Notes will be convertible at the option of the holders thereof only under the following circumstances: (1) during any fiscal quarter commencing after the fiscal quarter ended on January 28, 2024 (and only during such fiscal quarter), if the last reported sale price of the Company's common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period after any ten consecutive trading day period in which, for each trading day of that period, the Trading Price (as defined in the 2028 Indenture), as determined following a request by a holder of the 2028 Notes in accordance with the procedures described in the Indenture, per $1,000 principal amount of the 2028 Notes for such trading day was less than 98% of the product of the last reported sale price of the Company's common stock and the conversion rate on each such trading day; (3) if the Company calls such 2028 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, but only with respect to the 2028 Notes called (or deemed called as provided in the 2028 Indenture) for redemption; or (4) upon the occurrence of specified corporate events described in the 2028 Indenture. As of April 27, 2025, one of the conditions allowing the holders of the 2028 Notes to convert had been met. The trading price of the Company's common stock remained above 130% of the applicable $20.37 conversion price for at least 20 trading days during the 30 consecutive-trading day period ending on, and including April 25, 2025 (the last trading day of the fiscal quarter ended April 27, 2025) resulting in the right of the holders of the 2028 Notes to convert the 2028 Notes beginning April 28, 2025 through July 24, 2025 (the last trading day of the fiscal quarter ending July 27, 2025). Should the holders of the 2028 Notes elect to convert some or all of the 2028 Notes, the Company intends to draw on its Revolving Credit Facility to settle the obligation.

In addition, on or after August 1, 2028 until the close of business on the second scheduled trading day immediately preceding the maturity date of the 2028 Notes, holders of the 2028 Notes may convert all or a portion of their 2028 Notes, regardless of the foregoing conditions. Upon conversion, the 2028 Notes will be settled in cash up to the aggregate principal amount of the 2028 Notes to be converted, and in cash, shares of the Company's common stock or any combination thereof, at the Company's option, in respect of the remainder, if any, of the Company's conversion obligation in excess of the aggregate principal amount of the 2028 Notes being converted.

The Company may not redeem the 2028 Notes prior to November 5, 2026. The Company may redeem for cash all or any portion of the 2028 Notes (subject to the limitation described below), at the Company's option, on or after November 5, 2026 and before the 41st scheduled trading day immediately preceding the maturity date if the last reported sale price of the Company's common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides the related notice of sale price redemption, at a redemption price equal to 100% of the principal amount of the 2028 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company redeems less than all the outstanding 2028 Notes, at least $75.0 million aggregate principal amount of the 2028 Notes must be outstanding and not subject to redemption as of the relevant redemption notice date. No sinking fund is provided for the 2028 Notes.

Upon the occurrence of a Fundamental Change (as defined in the 2028 Indenture) prior to the maturity date of the 2028 Notes, holders of the 2028 Notes may require the Company to repurchase all or a portion of the 2028 Notes for cash at a price equal to 100% of the principal amount of the 2028 Notes to be repurchased, plus any accrued and unpaid interest to, but excluding, the Fundamental Change Repurchase Date (as defined in the 2028 Indenture).

On July 11, 2024 and July 15, 2024, the Company entered into separate, privately negotiated exchange agreements (the "Exchange Agreements") with certain holders of the 2028 Notes. Pursuant to the Exchange Agreements, on July 24, 2024 certain holders exchanged with the Company approximately $188.1 million in aggregate principal amount of the 2028 Notes held by them for an aggregate of 10,378,431 shares of the Company's common stock, which number of shares was determined over an averaging period that commenced on July 12, 2024.

Interest expense was comprised of the following components for the periods presented:

The Company's effective tax rate differs from the statutory federal income tax rate of 21% primarily due to the regional mix of income, changes in valuation allowance, research and development ("R&D") tax credits and impact of global intangible low-taxed income ("GILTI"). The Tax Cuts and Jobs Act requires R&D costs incurred for tax years beginning after December 31, 2021 to be capitalized and amortized ratably over five or fifteen years for tax purposes, depending on where the research activities are conducted. The Company has elected to treat GILTI as a period cost and the additional capitalization of R&D costs within GILTI increases the Company's provision for income taxes.

In December 2021, the Organization for Economic Cooperation and Development ("OECD") published a framework for a new global minimum tax of 15% ("Pillar Two") on income arising in low-tax jurisdictions, and certain governments in countries where the Company operates have enacted local Pillar Two legislation, with an effective date from January 1, 2024. The Company currently does not expect Pillar Two to have a material impact on its provision for income taxes; however, any future changes in OECD guidance or interpretations could adversely impact the Company’s initial assessment.

The Company uses a two-step approach to recognize and measure uncertain tax positions ("UTP"). The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained in audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon ultimate settlement.

A reconciliation of the beginning and ending amount of gross unrecognized tax benefits (before the federal impact of state items) is as follows:

Included in the balance of gross unrecognized tax benefits at April 27, 2025 and January 26, 2025 are $5.2 million and $4.8 million, respectively, of net tax benefits (after the federal impact of state items), that, if recognized, would impact the effective tax rate, prior to consideration of any required valuation allowance. The Company does not anticipate any events to occur during the next twelve months that would materially reduce the unrealized tax benefit as currently stated in the Company's condensed consolidated balance sheets.

The liability for UTP is reflected in the Balance Sheets as follows:        

The Company's policy is to include net interest and penalties related to unrecognized tax benefits in the "Provision (benefit) for income taxes" in the Statements of Operations.

Tax years prior to 2020 (the Company's fiscal year 2021) are generally not subject to examination by the U.S. Internal Revenue Service ("IRS") except for items involving tax attributes that have been carried forward to tax years whose statute of limitations remains open. The Company's fiscal year 2023 federal income tax return is currently in the preliminary stages of examination by the IRS, and any potential adjustments are unknown at this time. For state returns in the U.S., the Company is generally not subject to income tax examinations for calendar years prior to 2019 (the Company's fiscal year 2020). The Company has a significant tax presence in Switzerland for which Swiss tax filings have been examined through fiscal year 2020. The Company is also subject to routine examinations by various foreign tax jurisdictions in which it operates. The Company believes that adequate provisions have been made for any adjustments that may result from tax examinations. However, the outcome of tax examinations cannot be predicted with certainty. If any issues addressed in the Company's tax examinations are resolved in a manner not consistent with the Company's expectations, the Company could be required to adjust its provision for income taxes in the period such resolution occurs.

The Company's regional income or loss before taxes and equity method income or loss was as follows:

The Company has operating leases for real estate, vehicles, and office equipment, which are accounted for in accordance with ASC 842, "Leases." Real estate leases are used to secure office space for the Company's administrative, engineering, production support and manufacturing activities. The Company's leases have remaining lease terms of up to approximately seven years, some of which include options to extend the leases for up to five years, and some of which include options to terminate the leases within one year.

The components of lease expense were as follows:

Supplemental cash flow information related to leases was as follows: